Powder: -20°C for 3 years | In solvent: -80°C for 1 year
SR-3306 is a potent and highly inhibitor of brain penetrant JNK.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 44.00 | |
5 mg | In stock | $ 105.00 | |
10 mg | In stock | $ 163.00 | |
25 mg | In stock | $ 319.00 | |
50 mg | In stock | $ 578.00 | |
100 mg | In stock | $ 928.00 | |
500 mg | In stock | $ 1,860.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 116.00 |
Description | SR-3306 is a potent and highly inhibitor of brain penetrant JNK. |
In vitro | H9c2 cells treated with H2O2/FeSO4 (100 μM) are ~40% viable, whereas the addition of SR-3306(500 nM) or SR3562(500 nM ) to cells treated with H2O2/FeSO4(100 μM) increases viability to ~90%, and the addition of 10 μM Tat-Sab peptide to cells treated with H2O2/FeSO4 (100 μM) increases viability to ~70% compared with 98% viability in untreated cells [2]. |
In vivo | SR-3306 (10 mg/kg/day (s.c.) for 14 days) decreases d-amphetamine-induced circling by 87% compared to 6-hydroxydopamine (6-OHDA)-lesioned animals given vehicle. Steady-state brain levels of SR-3306 at day 14 are 347 nM, which is approximately 2-fold higher than the cell-based IC50 for this compound. SR-3306 (10 mg/kg/day (s.c.) for 14 days) administration increases the number of tyrosine hydroxylase immunoreactive (TH+) neurons in the SNpc by 6-fold and reduces the loss of the TH+ terminals in the striatum relative to the corresponding side of 6-OHDA-lesioned rats that receive the only vehicle (p<0.05). Finally, immunohistochemical staining for phospho-c-jun (p-c-jun) reveals that SR-3306 (10 mg/kg/day (s.c.) for 14 days) produces a 2.3-fold reduction of the number of immunoreactive neurons in the substantia nigra pars compacta (SNpc) relative to vehicle-treated rats. In lean mice, intraperitoneal (i.p.) or intracerebroventricular (i.c.v.) administration of SR-3306 reduces food intake and body weight. SR11935(i.p. and i.c.v.) treatment exert similar anorectic effects as SR3306, which suggests JNK2 or JNK3 mediates aspect of the anorectic effect by pan-JNK inhibition. Furthermore, SR-3306 (daily i.p. injection, 7 days) prevents the increases in food intake and weight gain in lean mice upon high-fat diet feeding, and this injection paradigm reduced high-fat intake and obesity in diet-induced obese mice [1][3]. |
Molecular Weight | 490.56 |
Formula | C28H26N8O |
CAS No. | 1128096-91-2 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 125 mg/mL (254.81 mM), Sonification is recommended.
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
SR-3306 1128096-91-2 MAPK JNK SR 3306 Inhibitor SR3306 inhibit inhibitor